You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
ArriVent is a company surfaced as a portfolio company of general-catalyst and added to the API Evangelist network as a stub for enrichment. Sector: healthcare. This profile is a lead awaiting the enrichment pipeline.
Backed by: general-catalyst
About
ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with difficult-to-treat diseases, beginning with cancers.